Pankova Valeriya, Thway Khin, Jones Robin L, Huang Paul H
Division of Molecular Pathology, The Institute of Cancer Research, Sutton, United Kingdom.
Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Front Cell Dev Biol. 2021 Dec 9;9:763640. doi: 10.3389/fcell.2021.763640. eCollection 2021.
Soft tissue sarcomas are rare cancers of mesenchymal origin or differentiation comprising over 70 different histological subtypes. Due to their mesenchymal differentiation, sarcomas are thought to produce and deposit large quantities of extracellular matrix (ECM) components. Interactions between ECM ligands and their corresponding adhesion receptors such as the integrins and the discoidin domain receptors play key roles in driving many fundamental oncogenic processes including uncontrolled proliferation, cellular invasion and altered metabolism. In this review, we focus on emerging studies that describe the key ECM components commonly found in soft tissue sarcomas and discuss preclinical and clinical evidence outlining the important role that these proteins and their cognate adhesion receptors play in sarcomagenesis. We conclude by providing a perspective on the need for more comprehensive in-depth analyses of both the ECM and adhesion receptor biology in multiple histological subtypes in order to identify new drug targets and prognostic biomarkers for this group of rare diseases of unmet need.
软组织肉瘤是起源于间充质或具有间充质分化特征的罕见癌症,包含70多种不同的组织学亚型。由于其间充质分化特性,肉瘤被认为会产生并沉积大量细胞外基质(ECM)成分。ECM配体与其相应的黏附受体(如整合素和盘状结构域受体)之间的相互作用在驱动许多基本致癌过程中起着关键作用,这些过程包括不受控制的增殖、细胞侵袭和代谢改变。在本综述中,我们聚焦于描述软组织肉瘤中常见关键ECM成分的新兴研究,并讨论临床前和临床证据,这些证据概述了这些蛋白质及其同源黏附受体在肉瘤发生中所起的重要作用。我们最后指出,需要对多种组织学亚型中的ECM和黏附受体生物学进行更全面深入的分析,以便为这组未满足需求的罕见疾病确定新的药物靶点和预后生物标志物。